Auteurs
Caccialupi Da Prato L - Rezzag Lebza A - Consumi A - Tessier M - Srinivasan A - Rivera C - Laurin J - Pellegrino C
Journal
Frontiers in molecular neuroscience
Abstract
Traumatic brain injury (TBI) is a major cause of disabilities in industrialized countries. Cognitive decline typically occurs in the chronic phase of the condition, following cellular and molecular processes. In this study, we described the use of KCC2, a neuronal-specific potassium-chloride cotransporter, as a potent biomarker to predict cognitive dysfunction after TBI.